- Home
- IGR vs HQL Comparison
IGR vs HQL Comparison
Compare IGR & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | IGR | HQL |
|---|---|---|
| Founded | 2004 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 645.2M | 544.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IGR | HQL |
|---|---|---|
| Price | $4.71 | $17.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 603.3K | 105.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 13.93% | 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.04 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.15 | $11.88 |
| 52 Week High | $5.37 | $18.10 |
Technical Indicators
Market Signals| Indicator | IGR | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 54.71 | 50.37 |
| Support Level | $4.65 | $16.40 |
| Resistance Level | $4.89 | $17.46 |
| Average True Range (ATR) | 0.07 | 0.32 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 61.54 | 41.22 |
Price Performance
Historical ComparisonAbout IGR CBRE Global Real Estate Income Fund of Beneficial Interest
CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.